Dental implants and natural teeth occupy the same oral environment yet behave as distinct biological entities. This study set out to quantify those differences in clinically healthy conditions, comparing probing depth, keratinized mucosa dimensions, subgingival microbiota composition, and MMP-8 expression between 79 implants and their 79 contralateral homologous teeth in 47 patients. Implants spanned three platform designs — External Hexagon (EH), Internal Hexagon (IH), and Morse Taper (MT) — allowing a secondary analysis of whether connection geometry modulates any of these parameters.

Clinically, implants presented significantly greater probing depth and reduced keratinized mucosa dimensions compared with teeth, confirming what clinicians observe daily but rarely quantify in matched pairs. Microbiologically, total bacterial loads were comparable between the two sites, but the species distribution diverged. Teeth harbored higher levels of Actinomyces naeslundii I, Actinomyces oris, Prevotella intermedia, and Treponema denticola. Implants, by contrast, showed greater prevalence of Prevotella nigrescens, Aggregatibacter actinomycetemcomitans (serotypes A+B), and Selenomonas noxia — the latter two particularly concentrated in the EH group, suggesting that macro-geometry of the implant-abutment connection may influence microbial colonization patterns.

The most clinically provocative finding concerns MMP-8. Measured in peri-implant and gingival crevicular fluid by quantitative analysis, MMP-8 levels were approximately 29% higher around implants than around teeth, and this difference held regardless of implant platform design. MMP-8 is a collagenase predominantly released by neutrophils and a recognized biomarker of connective tissue breakdown. Its elevation at clinically healthy implant sites — without correlation to probing depth, bleeding on probing, or keratinized mucosa dimensions, but correlated exclusively with crevicular fluid volume — points to a baseline inflammatory tone intrinsic to the peri-implant microenvironment.

For the practicing implantologist and periodontist, these findings carry several implications. First, the peri-implant sulcus is not a biological replica of the gingival sulcus: even in health, it sustains a distinct microbial ecology and a measurably higher proteolytic activity. Second, the absence of clinical signs of disease does not equate to biological quiescence around implants. Third, the enrichment of potentially pathogenic species — including A. actinomycetemcomitans — in EH implants warrants attention when selecting implant systems in patients with a history of aggressive periodontitis or compromised immune response. Finally, MMP-8 in crevicular fluid emerges as a candidate early-warning biomarker for peri-implant tissue stress, potentially detectable before any clinical parameter signals disease. Incorporating fluid-based biomarker assessment into implant maintenance protocols may offer a more sensitive window into peri-implant biology than probing alone.